AI-generated summary
The authors report four cases of androgenetic alopecia treated with a non-ablative erbium glass fractional laser followed by topical finasteride and growth factors. All four patients showed a positive response, with photographs taken two weeks after the last session showing improved regrowth and density. The abstract describes only four cases and does not report a control group.
- Participants
- 4
- Who or what was studied
- Four patients with androgenetic alopecia (male and female pattern hair loss)
- Limits stated in the abstract
- The report describes only four cases with no control group, and the abstract states no formal statistical analysis.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Androgenetic alopecia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.